Neogenomics (NEO) Interest & Investment Income (2013 - 2026)
Neogenomics (NEO) reported Interest & Investment Income of $1.3 million for Q1 2026, down 65.79% on a YoY basis from $3.7 million in Q1 2025, and down 16.41% quarter-over-quarter from $1.5 million in Q4 2025.
Neogenomics (NEO) Interest & Investment Income (2013 - 2026) Analysis & Trends
Neogenomics has reported Interest & Investment Income for 6 years, with the latest figure at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 65.79% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $6.6 million (down 61.75% YoY), and the FY2025 full-year result was $9.1 million, down 50.78% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $1.3 million, down from $1.5 million in the prior quarter.
- The five-year high for Interest & Investment Income was $4.8 million in Q4 2023, with the low at $1.3 million in Q1 2026.
- Historically, Interest & Investment Income has averaged $3.5 million across 4 years, with a median of $4.3 million in 2023.
- Annual changes were most pronounced in 2024 — Interest & Investment Income grew 6.59% — and 2025, when it plunged 66.55%.
- Neogenomics' Interest & Investment Income stood at $4.8 million in 2023, then fell by 10.67% to $4.3 million in 2024, then tumbled by 64.81% to $1.5 million in 2025, then decreased by 16.41% to $1.3 million in 2026.
- The last three Interest & Investment Income figures came in at $1.3 million (Q1 2026), $1.5 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 6.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 233.00 Mn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | 27.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 597,000.00 |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 13.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | 10.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | 11.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | - |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn | 1.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 3.72 Mn |
| Dec 31, 2024 | 4.33 Mn |
| Sep 30, 2024 | 4.67 Mn |
| Jun 30, 2024 | 4.59 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2023 | 4.85 Mn |
| Sep 30, 2023 | 4.53 Mn |
| Jun 30, 2023 | 4.31 Mn |
| Jun 30, 2014 | -253,000.00 |
| Jun 30, 2013 | -232,000.00 |